Contact this trialFirst, we need to learn more about you.
Radiation
Talazoparib + Radiation for Gynecologic Cancers
Recruiting1 awardPhase 1
Baltimore, Maryland
This trial looks at the side effects and best dose of talazoparib when given with radiation therapy for treating patients with recurrent gynecologic cancers. Talazoparib may stop cancer growth by blocking some enzymes needed for cell growth. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving talazoparib with radiation therapy may work better in treating patients with gynecologic cancers.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service